HomeCVKD • NASDAQ
add
Cadrenal Therapeutics Inc
Previous close
$16.55
Day range
$16.13 - $17.00
Year range
$5.40 - $32.55
Market cap
29.00M USD
Avg Volume
72.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.46M | 115.30% |
Net income | -2.41M | -132.31% |
Net profit margin | — | — |
Earnings per share | -2.18 | — |
EBITDA | -2.46M | -115.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.36M | -52.09% |
Total assets | 4.68M | -49.75% |
Total liabilities | 1.27M | 123.92% |
Total equity | 3.41M | — |
Shares outstanding | 1.78M | — |
Price to book | 6.00 | — |
Return on assets | -121.34% | — |
Return on capital | -165.86% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.41M | -132.31% |
Cash from operations | -2.20M | -250.64% |
Cash from investing | — | — |
Cash from financing | 1.53M | -76.52% |
Net change in cash | -673.27K | -111.45% |
Free cash flow | -1.33M | -429.34% |
About
Founded
2022
Website
Employees
4
